E
Sutro Biopharma, Inc. STRO
$0.8578 $0.01021.20% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -67.70% -113.31% -112.99% 28.12% 12.76%
Total Depreciation and Amortization 6.35% 5.67% 5.90% 7.08% 11.23%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 21.37% 39.56% -12.90% -15.01% 816.52%
Change in Net Operating Assets -693.43% 161.59% 125.89% -54.90% -83.23%
Cash from Operations -233.08% -68.75% -71.61% 29.30% -48.85%
Capital Expenditure -6.23% -0.18% 28.20% 44.38% 55.33%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 248.68% 4,213.91% 56,576.73% 1,020.83% -719.68%
Cash from Investing 243.76% 2,000.21% 5,668.50% 687.69% -969.48%
Total Debt Issued -- -- -- -- --
Total Debt Repaid 100.00% 100.00% 67.34% 42.34% 17.34%
Issuance of Common Stock -98.64% 3,129.83% 588.10% 232.34% 59.53%
Repurchase of Common Stock 23.87% 23.73% -3.88% 1.02% 12.43%
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -100.00% -102.53%
Cash from Financing -98.81% -22.19% -31.62% -40.51% -55.33%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 81.46% 1,401.72% 449.75% 720.48% -192.53%